Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT - RBC LIFE SCIENCES, INC. | pressrelease2013_08x27stoc.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 28, 2013
______________________RBC Life Sciences, Inc.______________________ (Exact name of registrant as specified in its charter) | ||
_______NEVADA_______ (State or other jurisdiction of incorporation) | _______000-50417_________ (Commission File Number) | _______91-2015186________ (IRS Employer Identification No.) |
2301 CROWN COURT, IRVING, TEXAS (Address of principal executive offices) | ____________75038_____________ (Zip Code) | |
Registrant's telephone number, including area code __________972-893-4000______________ | ||
__________________________N/A____________________________ (Former name or former address, if changed since last report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events.
On August 28, 2013, RBC Life Sciences, Inc. (the "Company") issued a press release announcing that its Board of Directors adopted a program to repurchase, at management's discretion, up to 111,000 shares, representing 5% of the shares of the Company's currently outstanding common stock.
A copy of the Company's press release is attached as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit | |
Number | Description |
99.1 | RBC Life Sciences, Inc. Press Release Dated August 28, 2013 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 28, 2013
RBC Life Sciences, Inc. | |
By: /s/ Richard S. Jablonski | |
Name: Richard S. Jablonski | |
Title: Vice President - Finance and Chief Financial Officer | |
EXHIBIT INDEX
Exhibit | |
Number | Description |
99.1 | RBC Life Sciences, Inc. Press Release Dated August 28, 2013 |